
Study Period | 2019 - 2030 |
Market Size (2025) | USD 1.73 Billion |
Market Size (2030) | USD 2.56 Billion |
CAGR (2025 - 2030) | 8.14 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Automated External Defibrillator (AED) Market Analysis
The Automated External Defibrillator Market size is estimated at USD 1.73 billion in 2025, and is expected to reach USD 2.56 billion by 2030, at a CAGR of 8.14% during the forecast period (2025-2030).
The automated external defibrillators market is driven by various factors, growing prevalence of cardiovascular diseases (CVDs), the growing awareness of cardiac arrest and related complications, and technological advancements in automated external defibrillators. Automated external defibrillators can save lives in emergencies by restoring normal heart rhythms. Hence, the rising prevalence of cardiovascular diseases, especially cardiac arrest, is a primary driver for the market growth. For instance, according to the British Heart Foundation ‘Global Heart & Circulatory Diseases Factsheet’ published in January 2024, the most common heart condition that affected the population in the United Kingdom was coronary (ischemic) heart disease. Furthermore, as per the same source, 1.1 million people in England in 2023 were affected by various heart diseases. Given the high prevalence of CAD, which heightens the risk of heart attacks, there's a projected surge in demand for automated external defibrillators. This trend positions the market for significant growth in the foreseeable future.
Moreover, manufacturers are focusing on producing lightweight, compact, and portable AEDs. For instance, in January 2023, Avive Solutions, Inc., received United States Food and Drug Administration (FDA) pre-market approval for its Avive AED, a unique handheld automated external defibrillator (AED). These devices are designed to be easy to carry and operate, allowing bystanders with no medical background to use them effectively in emergencies, thereby boosting the market growth over the study period.
Furthermore, the rise of telemedicine and virtual healthcare presents an opportunity for AEDs to be integrated with remote monitoring services, enabling healthcare providers to track AED usage and potentially intervene in real-time. However, the regulatory landscape for AEDs can be complex, and manufacturers need to comply with various international standards and certifications, such as those set by the FDA, CE, and other authorities. Meeting these requirements can increase production costs and slow down market entry. In addition, high initial investment costs can limit widespread adoption of AEDs, particularly in emerging markets which is expected to hinder the market growth over the forecast period.
Automated External Defibrillator Market Insights and Trends
The Fully Automated External Defibrillators Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
By analysis type, the fully automated external defibrillators segment is estimated to have a market size of USD 1.20 billion in 2024, and it is expected to reach USD 1.79 billion by 2029 while witnessing a CAGR of 8.25% over the forecast period (2024 - 2029).
Fully automated AEDs (FAEDs) are designed to be user-friendly, with no need for the user to manually analyze the heart rhythm or deliver the shock. The device automatically detects the heart's rhythm and, if necessary, delivers a shock. This makes FAEDs especially appealing in public spaces and workplaces, where the user may not have medical training. The FAEDs segment in the automated external defibrillator market is expected to experience notable growth in the coming years. This growth is driven by several key factors, ranging from the increasing demand for ease of use to advancements in AED technology.
In emergencies, time is critical, and FAEDs reduce response time by automatically determining when a shock is necessary, thus improving survival rates. For instance, in February 2024, the Udgam Group of Schools, encompassing Udgam School for Children, Zebar School for Children, Satellite School for Children, and Bodakdev School for Children, installed an Automated External Defibrillator (AED) machine on its premises. This move was part of a larger campaign advocating for the deployment of this life-saving technology in public areas, with schools and colleges taking the lead. Programs centered around AEDs in schools have shown a significant survival rate for those experiencing sudden cardiac arrests in high schools across Asia Pacific countries like India. Hence, as public awareness about sudden cardiac arrest and the need for immediate defibrillation increases, demand for fully automated AEDs grows, which is expected to boost the segment growth over the forecast period.
Moreover, FAEDs are increasingly being integrated with advanced technologies such as voice guidance, visual prompts, real-time ECG analysis, and smart connectivity. This makes them more efficient and capable of providing better user guidance during emergencies. However, FAEDs are generally more expensive than semi-automated devices. The higher initial cost may deter small organizations, educational institutions, or smaller public spaces from adopting them, even though they offer a higher level of ease and reliability.

Hospitals / Clinics Under End User Segment is Expected to Dominate the Market Over the Forecast Period
By end user, the hospitals / clinics segment held the major AED market share with an estimated market size of USD 0.53 billion in 2024 which is forecast to reach USD 0.76 billion by 2029 with a CAGR of 7.63% over the forecast period.
AEDs used in hospitals and clinics are typically more complex than public AEDs, which require trained medical personnel to operate them. Hospital defibrillators are designed for manual external defibrillation, requiring doctors to assess how much shock energy should be delivered to the patient and decide when and how often to deliver the shock. Factors such as the implementation of AEDs in hospitals and clinics, the rise in adoption of advanced AEDs, and favorable funding activities by government organizations to improve the healthcare infrastructure in hospitals are expected to support the segment growth over the forecast period.
The automated external defibrillator market research report is segmented by analysis type and end user. By analysis type, the market is segmented into semi-automated external defibrillators and fully automated external defibrillators. By end user, the market is segmented into hospitals/clinics, home care, and other end users. Each of these segments is experiencing growth due to factors like the rising burden of cardiovascular diseases, and technological advancements in AEDs. In addition, advanced life support (ALS) AEDs are sophisticated defibrillators designed for use by trained medical professionals, offering features such as real-time monitoring, ECG analysis, and manual override options for more precise control during cardiac emergencies.
North America is Expected to Dominate the Market Over the Forecast Period
By geography, the North American region is likely to hold a major share with an estimated market size of USD 0.88 billion in 2024, expected to reach USD 1.25 billion by 2029 with a CAGR of 7.23% over the forecast period. The North American automated external defibrillator market is experiencing robust growth, driven by a combination of regulatory support, rising healthcare awareness, technological advancements, and the increasing prevalence of cardiovascular diseases (CVDs). The American Heart Association (AHA) and American Red Cross also promote the installation of AEDs in public spaces and encourage training in cardiopulmonary resuscitation (CPR) and defibrillation, further increasing awareness and adoption.
The increasing prevalence of cardiovascular diseases such as heart attack, heart failure, and coronary heart disease, among others, is one of the significant factors driving the market growth over the forecast period. For instance, according to the data updated by the Centers for Disease Control and Prevention in May 2023, every 40 seconds, a heart attack occurs in the United States. Also, about 805,000 Americans experience a heart attack each year. Hence, the rising burden of cardiovascular diseases in the coming years will increase the demand for automated external defibrillators, elevating the market growth over the forecast period.
Furthermore, strategic activities by market leaders and players, such as acquisitions and collaborations, are also expected to enhance market growth in the country. For instance, in January 2024, Safe Life broadened its North American footprint with the acquisition of AED4Life. This achievement is a continuation of Safe Life's successful integration of multiple acquisitions across North America, solidifying its ambition to transform the global defibrillation landscape. AED4Life is eager to collaborate with Safe Life, championing the mission of distributing AEDs throughout Canada. As a result, this regional expansion is poised to drive market growth in the country during the forecast period.
By geography, the global market is segmented into North America (United States, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa), and South America (Brazil, Argentina, Rest of South America). Many emerging economies are seeing an increase in healthcare infrastructure, disposable income, and awareness of health risks.

Automated External Defibrillator Industry Overview
The automated external defibrillators industry is semi-consolidated with major local and international key players. The competitive landscape of the market is dynamic and evolving, with a mix of established players and newer entrants driving innovation and market expansion. Some of the key players currently dominating the market are Asahi Kasei Corporation (ZOLL Medical Corporation), Koninklijke Philips NV, Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Stryker, CU Medical Systems Inc., MEDIANA Co. Ltd, BPL Medical Technologies, Progetti Srl, Bexen Cardio (Bexen), Corpuls. The key players in the AED market are focused on technological advancements, regulatory compliance, distribution strategies, and customer service to maintain or gain market share. For instance, in January 2023, Avive Solutions Inc., a United States-based tech firm specializing in automated external defibrillators, unveiled its FDA-approved Avive Connect AED.
Similar product launches expand the presence of these AED devices in various countries which likely drive the usage of these devices. In addition, companies are expanding their distribution networks to reach diverse sectors, including public spaces, corporate offices, healthcare institutions, and sports facilities.
Automated External Defibrillator (AED) Market Leaders
-
Asahi Kasei Corporation
-
Stryker Corporation
-
Nihon Kohden Corporation
-
Koninklijke Philips NV
-
Mediana Co. Ltd.
- *Disclaimer: Major Players sorted in no particular order

Automated External Defibrillator (AED) Market News
- September 2024: the PulsePoint Foundation revealed that ZOLL transferred the National AED Registry to them. With this donation, emergency call takers will have enhanced access to known locations of AEDs (automated external defibrillators) during cardiac arrest call processing.
- February 2024: Schiller AG installed its FRED PA-1 automated external defibrillators in railroad stations in Mumbai. The installations have been strategically placed in the station master's room at Vile Parle and Santacruz stations to ensure round-the-clock accessibility and quick response in case of emergencies.
- February 2024: Kearsney Abbey bolstered its life-saving equipment network with the installation of a new defibrillator. The newly installed automated external defibrillator (AED), mounted on the wall near the cafe entrance, stands ready to assist visitors during any medical emergencies at the park.
- January 2024: ZOLL Medical Corporation received approval from the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU Medical Device Regulation (MDR) Certification for its ZOLL AED 3 defibrillator. The intent of the EU MDR is to ensure a high standard of safety and quality for medical devices that are produced in or supplied to member countries of the European Union.
Automated External Defibrillator (AED) Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Cardiovascular Diseases
- 4.2.2 Technological Advancements in the Field of Automated External Defibrillator
- 4.2.3 Increasing Investments by Private Players
-
4.3 Market Restraints
- 4.3.1 Stringent Regulations
- 4.3.2 Lack of Awareness and Early Corrective Measures About Sudden Cardiac Arrest (SCA)
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD Billion)
-
5.1 By Analysis Type
- 5.1.1 Semi-automated External Defibrillators
- 5.1.2 Fully-automated External Defibrillators
-
5.2 By End User
- 5.2.1 Hospitals/clinics
- 5.2.2 Home Care
- 5.2.3 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 CU Medical Systems Inc.
- 6.1.2 MEDIANA Co. Ltd
- 6.1.3 BPL Medical Technologies
- 6.1.4 Progetti Srl
- 6.1.5 Bexen Cardio (Bexen)
- 6.1.6 Corpuls
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Automated External Defibrillator (AED) Industry Segmentation
As per the report's scope, an automated external defibrillator (AED) is a lightweight and portable device that delivers an electric shock from the chest to the heart. The shock can potentially stop an irregular heartbeat and allow a normal rhythm to resume after a sudden cardiac arrest (SCA).
The automated external defibrillator market is segmented by analysis type, end user, and geography. By analysis type, the market is segmented into semi-automated external defibrillators and fully automated external defibrillators. By end user, the market is segmented into hospitals/clinics, home care, and other end users. By geography, the global market is segmented into North America (United States, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa), and South America (Brazil, Argentina, Rest of South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD billion) for the above segments.
By Analysis Type | Semi-automated External Defibrillators | ||
Fully-automated External Defibrillators | |||
By End User | Hospitals/clinics | ||
Home Care | |||
Other End Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Automated External Defibrillator (AED) Market Research FAQs
How big is the external defibrillator market?
The automated external defibrillator market size is expected to reach USD 1.73 billion in 2025 and grow at a CAGR of 8.14% to reach USD 2.56 billion by 2030.
What factors are driving the growth of the AED market?
The growth of the AED market is driven by factors such as the increasing prevalence of cardiovascular diseases, regulatory mandates for AEDs in public and workplace settings, advancements in AED technology, growing public awareness of sudden cardiac arrest, and the expanding adoption of AEDs in both healthcare and non-medical environments.
Who are the key players in the AED industry?
Asahi Kasei Corporation, Stryker Corporation, Nihon Kohden Corporation, Koninklijke Philips NV and Mediana Co. Ltd. are the major companies operating in the automated external defibrillator market.
What challenges are faced by the AED market?
The AED market faces challenges such as high initial costs, maintenance expenses, a lack of widespread training and awareness, regulatory complexities, and market saturation in developed regions.
Which regions have the highest demand for AEDs?
The regions with the highest demand for AEDs are North America, Europe, and Asia-Pacific, driven by regulatory requirements, increasing healthcare awareness, and a growing focus on public safety.